Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 6/20 | 0.41 |
| ▸ | PHGDH | O43175 | 6/20 | 0.40 |
| ▸ | DRD4 | P21917 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.38 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.36 |
| ▸ | P2RX2 | Q9UBL9 | 2/20 | 0.36 |
| ▸ | ABL1 | P00519 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL4505929 | 0.93 | CYP1A2 (0.48) | GRM5PHGDHDRD4CYP1A2CYP3A4 | |
| Trifluoroacetic Acid SCHEMBL4501514 | 0.90 | PDK1 (0.47) | GRM5PHGDHDRD4PDK1NPC1 | |
| Trifluoroacetic Acid SCHEMBL4506794 | 0.90 | DRD4 (0.42) | GRM5PHGDHDRD4CYP1A2CYP3A4 | |
| Trifluoroacetic Acid SCHEMBL4505112 | 0.89 | GRM5 (0.45) | GRM5PHGDHDRD4CYP1A2CYP3A4 | |
| Trifluoroacetic Acid SCHEMBL4498992 | 0.87 | PHGDH (0.40) | PHGDHDRD4CYP1A2CYP3A4NPC1 | |
| Trifluoroacetic Acid SCHEMBL4508112 | 0.86 | DRD4 (0.44) | GRM5PHGDHDRD4PDK1 | |
| Trifluoroacetic Acid SCHEMBL4503751 | 0.86 | DRD4 (0.45) | GRM5PHGDHDRD4 | |
| Trifluoroacetic Acid SCHEMBL4504324 | 0.86 | PHGDH (0.46) | PHGDHPDK1NPC1 | |
| Trifluoroacetic Acid SCHEMBL4516141 | 0.86 | PHGDH (0.40) | GRM5PHGDHPDK1ABL1 | |
| Trifluoroacetic Acid SCHEMBL4504667 | 0.86 | EPHA2 (0.41) | GRM5PHGDHDRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090325956-A1 | Aromatic amine derivative and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090325956-A1 | Aromatic amine derivative and use thereof | SCD, SCD5, SMS | GRM5 4026/4885PHGDH 1406/4885DRD4 2674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.